Insertable cardiac monitor‐guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol ( ICM‐REDUCE‐AF trial)
Annals of Noninvasive Electrocardiology · 2023
DOI: 10.1111/anec.13043 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Annals of Noninvasive Electrocardiology, 2023. Verfasst von Sinan S Tankut und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Rochester Medical Center, Rochester, New York, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Percutaneous catheter ablation (CA) to achieve pulmonary vein isolation is an effective treatment for drug‐refractory paroxysmal and persistent atrial fibrillation (AF). However, recurrence rates after a single AF ablation procedure remain elevated. Conventional management after CA ablation has mostly been based on clinical AF recurrence. However, continuous recordings with insertable cardiac monitors (ICMs) and patient‐triggered mobile app transmissions post‐CA can now be used to detect early recurrences of subclinical AF (SCAF). We hypothesize that early intervention following CA based on personalized ICM data can prevent the substrate progression that promotes the onset and maintenance of atrial arrhythmias.
Methods
This is a randomized, double‐blind (to SCAF data), single‐tertiary center clinical trial in which 120 patients with drug‐refractory paroxysmal or persistent AF are planned to undergo CA with an ICM. Randomization will be to an intervention arm ( n = 60) consisting of ICM‐guided early intervention based on SCAF and patient‐triggered mobile app transmissions versus a control arm ( n = 60) consisting of a standard intervention protocol based on clinical AF recurrence validated by the ICM. Primary endpoint is AF burden, which will be assessed from ICMs at 15 months post‐AF ablation. Secondary endpoints include healthcare utilization, functional capacity, and quality of life.
Conclusion
We believe that ICM‐guided early intervention will provide a novel, personalized approach to post‐AF ablation management that will result in a significant reduction in AF burden, healthcare utilization, and improvements in functional capacity and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, University of Rochester Medical Center, Rochester, New York, USA.
- Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
- Summit Medical Group, Short Hills, New Jersey, USA.
ORCID-Profile: Sinan S Tankut, Mehmet K Aktas
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Tankut, S. S., Huang, D. T., Zareba, W., Aktas, M. K., Rosero, S. Z., Steinberg, J., Henchen, J., Kutyifa, V., Strawderman, R. L., & Goldenberg, I. (2023). Insertable cardiac monitor‐guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol ( ICM‐REDUCE‐AF trial). Annals of Noninvasive Electrocardiology. https://doi.org/10.1111/anec.13043
Vancouver
Tankut SS, Huang DT, Zareba W, Aktas MK, Rosero SZ, Steinberg J, et al. Insertable cardiac monitor‐guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol ( ICM‐REDUCE‐AF trial). Annals of Noninvasive Electrocardiology. 2023. doi:10.1111/anec.13043
BibTeX
@article{Tankut2023,
author = {Tankut, Sinan S and Huang, David T and Zareba, Wojciech and Aktas, Mehmet K and Rosero, Spencer Z and Steinberg, Jonathan and Henchen, Jennifer and Kutyifa, Valentina and Strawderman, Robert L and Goldenberg, Ilan},
title = {Insertable cardiac monitor‐guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol ( ICM‐REDUCE‐AF trial)},
journal = {Annals of Noninvasive Electrocardiology},
year = {2023},
doi = {10.1111/anec.13043}
}
EUVIMED